Walgreens Boots Alliance (WBA) Upgraded by ValuEngine to “Buy”
Walgreens Boots Alliance (NASDAQ:WBA) was upgraded by investment analysts at ValuEngine from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Thursday, January 4th.
A number of other equities analysts have also recently weighed in on WBA. Jefferies Group reiterated a “buy” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a report on Thursday, September 7th. Needham & Company LLC reiterated a “buy” rating and set a $94.00 price target on shares of Walgreens Boots Alliance in a report on Sunday, September 10th. BidaskClub cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Tuesday, September 12th. Royal Bank of Canada started coverage on Walgreens Boots Alliance in a report on Tuesday, September 19th. They set an “outperform” rating and a $96.00 price target for the company. Finally, Raymond James Financial reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Wednesday, September 27th. Ten analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $86.00.
Shares of Walgreens Boots Alliance (WBA) traded up $1.12 during trading hours on Thursday, reaching $80.27. The company’s stock had a trading volume of 6,248,648 shares, compared to its average volume of 5,560,000. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48. The stock has a market cap of $79,520.00, a PE ratio of 22.17, a P/E/G ratio of 1.34 and a beta of 1.22. Walgreens Boots Alliance has a 12 month low of $63.82 and a 12 month high of $88.00.
Walgreens Boots Alliance declared that its Board of Directors has approved a share repurchase plan on Wednesday, October 25th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the pharmacy operator to repurchase shares of its stock through open market purchases. Stock buyback plans are often a sign that the company’s board of directors believes its stock is undervalued.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the sale, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Stefano Pessina purchased 98,858 shares of Walgreens Boots Alliance stock in a transaction on Monday, January 15th. The stock was bought at an average cost of $76.07 per share, for a total transaction of $7,520,128.06. The disclosure for this purchase can be found here. Company insiders own 14.80% of the company’s stock.
Hedge funds have recently bought and sold shares of the business. Hudock Capital Group LLC raised its position in shares of Walgreens Boots Alliance by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after acquiring an additional 6 shares in the last quarter. Westside Investment Management Inc. raised its position in shares of Walgreens Boots Alliance by 10.4% during the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after acquiring an additional 125 shares in the last quarter. Zions Bancorporation raised its position in shares of Walgreens Boots Alliance by 983.3% during the 3rd quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,239 shares in the last quarter. IHT Wealth Management LLC raised its position in shares of Walgreens Boots Alliance by 46.3% during the 2nd quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock worth $135,000 after acquiring an additional 2,199 shares in the last quarter. Finally, Bristlecone Advisors LLC acquired a new stake in shares of Walgreens Boots Alliance during the 3rd quarter worth about $135,000. 61.17% of the stock is currently owned by institutional investors.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.